• Skip to primary navigation
  • Skip to main content
Cathexis Consulting

Cathexis Consulting

Evaluation Experts

  • Our Services
  • Our Experience
  • Our Team
  • About Us
  • Blog
  • Certified B Corporation

March 14, 2016

Evaluation of the ACO – Executive Summary now up on the ACO website

The Canadian HIV Vaccine Initiative (CHVI) was established in 2007 as Canada’s contribution to the development of a safe, effective, and affordable HIV vaccine, accessible on a global scale. In 2011, the CHVI Research and Development Alliance Coordinating Office (ACO) was formed as a neutral organization aimed at facilitating collaboration, igniting synergies across disciplines, sectors, and geographic boundaries, capitalizing on Canada’s strengths, and ensuring that Canada is a leader in the HIV vaccine research effort.

In the past year, Cathexis conducted an evaluation of the ACO. The executive summary can be found here.

Categories: Buzz, News, Reports & Articles

365 Bloor St E, Suite 1006
Toronto, Ontario
M4W 3L4 Canada
Local: 416.469.9954
Toll-free: 1.877.469.9954
info@cathexisconsulting.ca
Cathexis acknowledges that our office is located on Indigenous land. This is the ancestral territory of many indigenous groups, including the Haudenosaunee Confederacy (also known as the Six Nations Confederacy), the Wendat, and the Mississaugas of the New Credit First Nation. We give our respect to the caretakers of this land, past, present, and future. See our About Us page to learn about our commitments to Truth and Reconciliation.